A detailed history of N Verses Capital, LLC transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, N Verses Capital, LLC holds 2,400 shares of FLGT stock, worth $40,680. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,400
Previous 2,200 9.09%
Holding current value
$40,680
Previous $43.2 Million 20.82%
% of portfolio
0.02%
Previous 0.03%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$19.6 - $25.06 $3,920 - $5,012
200 Added 9.09%
2,400 $52.2 Million
Q2 2024

Jul 31, 2024

BUY
$19.09 - $22.57 $41,998 - $49,654
2,200 New
2,200 $43.2 Million

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $513M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track N Verses Capital, LLC Portfolio

Follow N Verses Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of N Verses Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on N Verses Capital, LLC with notifications on news.